We are live on ! Find out more
Ken Fisher

Ken Fisher Fisher Asset Management

AUM $336B
1-Year Est. Return 34.66%
 

Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.

This Fund
S&P 500
This Quarter Est. Return
+0.04%
1 Year Est. Return
+34.66%
3 Year Est. Return
+114.19%
5 Year Est. Return
+138.25%
10 Year Est. Return
+1,100.41%
AUM
$161B
AUM Growth
+$1.73B
Cap. Flow
+$4.25B
Cap. Flow %
2.64%
Top 10 Hldgs %
31.07%
Holding
1,103
New
93
Increased
444
Reduced
375
Closed
75

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$1.24B
2
AAPL icon
Apple
AAPL
+$585M
3
STMP
Stamps.com, Inc.
STMP
+$111M
4
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$87.8M
5
TSM icon
TSMC
TSM
+$70.6M

Sector Composition

Rank Sector Weight
1 Technology 27.05%
2 Financials 11.79%
3 Healthcare 10.9%
4 Consumer Discretionary 10.36%
5 Communication Services 8.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTEC icon
676
Fidelity MSCI Information Technology Index ETF
FTEC
$21.1B
$398K ﹤0.01%
3,355
-537
-14% -$65.8K
NYF icon
677
iShares New York Muni Bond ETF
NYF
$1.39B
$397K ﹤0.01%
6,863
SDY icon
678
State Street SPDR S&P Dividend ETF
SDY
$23.8B
$380K ﹤0.01%
+3,234
New +$396K
PANW icon
679
Palo Alto Networks
PANW
$288B
$378K ﹤0.01%
4,740
+36
+0.8% +$2.53K
IAI icon
680
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
$1.37B
$377K ﹤0.01%
3,607
+666
+23% +$70.1K
HRTX icon
681
Heron Therapeutics
HRTX
$99.1M
$374K ﹤0.01%
35,007
+100
+0.3% +$1.22K
USHY icon
682
iShares Broad USD High Yield Corporate Bond ETF
USHY
$28.6B
$372K ﹤0.01%
8,973
-13,978
-61% -$581K
GPC icon
683
Genuine Parts
GPC
$18.1B
$366K ﹤0.01%
3,022
+54
+2% +$6.74K
OKTA icon
684
Okta
OKTA
$24.9B
$365K ﹤0.01%
1,537
+16
+1% +$3.97K
VXF icon
685
Vanguard Extended Market ETF
VXF
$31.4B
$361K ﹤0.01%
1,980
-897
-31% -$167K
FIEE
686
DELISTED
FI Enhanced Europe 50 ETN
FIEE
$358K ﹤0.01%
1,962
-86
-4% -$17.1K
VYM icon
687
Vanguard High Dividend Yield ETF
VYM
$82.6B
$351K ﹤0.01%
3,396
+880
+35% +$93K
EWY icon
688
iShares MSCI South Korea ETF
EWY
$24.1B
$348K ﹤0.01%
4,313
+27
+0.6% +$2.35K
INN
689
Summit Hotel Properties
INN
$727M
$342K ﹤0.01%
35,495
+13,314
+60% +$122K
HRC
690
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$340K ﹤0.01%
2,264
-650,846
-100% -$87.8M
VCSH icon
691
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$338K ﹤0.01%
4,100
+109
+3% +$9.01K
EFV icon
692
iShares MSCI EAFE Value ETF
EFV
$29.3B
$337K ﹤0.01%
6,635
+993
+18% +$51.5K
EPD icon
693
Enterprise Products Partners
EPD
$81.7B
$334K ﹤0.01%
15,446
-8,680
-36% -$197K
HPQ icon
694
HP
HPQ
$26.1B
$332K ﹤0.01%
12,130
+2,172
+22% +$62.4K
SNN icon
695
Smith & Nephew
SNN
$12.4B
$332K ﹤0.01%
9,660
-207
-2% -$8.15K
MGC icon
696
Vanguard Morningstar Mega Cap ETF
MGC
$10.4B
$328K ﹤0.01%
2,154
-532
-20% -$83.6K
BTI icon
697
British American Tobacco
BTI
$126B
$315K ﹤0.01%
8,919
+304
+4% +$11.4K
EL icon
698
Estee Lauder
EL
$31.6B
$315K ﹤0.01%
1,051
-46
-4% -$15K
IBB icon
699
iShares Biotechnology ETF
IBB
$9.53B
$314K ﹤0.01%
1,945
-412
-17% -$69.3K
RNST icon
700
Renasant Corp
RNST
$4.03B
$314K ﹤0.01%
8,708

Similar funds

Ken Fisher's Q3 2021 Portfolio in Review

As of Q3 2021, Ken Fisher held 1,103 positions worth $161B, up 1.1% from $159B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ken Fisher's Q3 2021 filing shows 93 new, 444 increased, 375 reduced and 75 closed positions. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 267,976 shares worth $37.2M. The largest sale was Visa, an estimated $1.24B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.

  • Ken Fisher's largest Q3 2021 buy was Biohaven Pharmaceutical Holding Company Ltd.: 267,976 shares worth $37.2M.
  • Ken Fisher added most to Meta Platforms (Facebook) in Q3 2021, an estimated $951M increase.
  • Ken Fisher's biggest Q3 2021 reduction was Visa, cutting an estimated $1.24B.
  • Ken Fisher fully exited Stamps.com, Inc. in Q3 2021, selling an estimated $111M.
  • Ken Fisher's ten largest holdings make up 31% of its $161B portfolio in Q3 2021.
  • Ken Fisher opened 93 new positions and closed 75 in Q3 2021.
  • Ken Fisher's portfolio value rose 1.1% quarter-over-quarter to $161B.

Based on Fisher Asset Management's 13F filing for Q3 2021, filed 26 Oct 2021.